Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kyle C Cuneo

Showing results (21-30 of 72) with videos related to

Pageof 8
Sort By:
Translational Oncology|November 10, 2018
Enhancing the Radiation Response in KRAS Mutant Colorectal Cancers Using the c-Met Inhibitor CrizotinibKyle C Cuneo, Ranjit K Mehta, Himabindu Kurapati, et al.
International Journal of Radiation Oncology, Biology, Physics|April 17, 2021
Modeling of Tumor Control Probability in Stereotactic Body Radiation Therapy for Adrenal TumorsPriscilla K Stumpf, Ellen D Yorke, Issam El Naqa, et al.
Angiogenesis|September 1, 2007
Hedgehog signaling in the murine melanoma microenvironmentLing Geng, Kyle C Cuneo, Michael K Cooper, et al.
Cancer Journal (Sudbury, Mass.)|July 20, 2023
Is Apparent Diffusion Coefficient Established as an Imaging Biomarker for Stereotactic Body Radiation Therapy Assessment in Hepatocellular Carcinoma?Yue Cao, Kyle C Cuneo, Joseph Evans, et al.
Translational Oncology|June 25, 2014
Low dose rate radiosensitization of hepatocellular carcinoma in vitro and in patientsKyle C Cuneo, Mary A Davis, Mary U Feng, et al.
ACS Omega|October 31, 2022
Sequential Method for Analysis of CTCs and Exosomes from the Same Sample of Patient BloodJianhui Zhu, Zhijing Tan, Jie Zhang, et al.
International Journal of Radiation Oncology, Biology, Physics|October 15, 2017
Imaging Findings Within the First 12 Months of Hepatocellular Carcinoma Treated With Stereotactic Body Radiation TherapyMishal Mendiratta-Lala, Everett Gu, Dawn Owen, et al.
Neuro-Oncology Practice|November 17, 2022
Efficacy and toxicity with radiation field designs and concurrent temozolomide for CNS lymphomaAnna M Laucis, Katherine Selwa, Yilun Sun, et al.
Cell Cycle (Georgetown, Tex.)|February 19, 2016
Dissociation of gemcitabine chemosensitization by CHK1 inhibition from cell cycle checkpoint abrogation and aberrant mitotic entryLeslie A Parsels, Daria M Tanska, Joshua D Parsels, et al.
Frontiers in Oncology|December 26, 2022
A human-in-the-loop based Bayesian network approach to improve imbalanced radiation outcomes prediction for hepatocellular cancer patients with stereotactic body radiotherapyYi Luo, Kyle C Cuneo, Theodore S Lawrence, et al.
Pageof 8

Showing results (21-30 of 72) with videos related to

Sort By:
Pageof 8
Translational Oncology|November 10, 2018
Enhancing the Radiation Response in KRAS Mutant Colorectal Cancers Using the c-Met Inhibitor CrizotinibKyle C Cuneo, Ranjit K Mehta, Himabindu Kurapati, et al.
International Journal of Radiation Oncology, Biology, Physics|April 17, 2021
Modeling of Tumor Control Probability in Stereotactic Body Radiation Therapy for Adrenal TumorsPriscilla K Stumpf, Ellen D Yorke, Issam El Naqa, et al.
Angiogenesis|September 1, 2007
Hedgehog signaling in the murine melanoma microenvironmentLing Geng, Kyle C Cuneo, Michael K Cooper, et al.
Cancer Journal (Sudbury, Mass.)|July 20, 2023
Is Apparent Diffusion Coefficient Established as an Imaging Biomarker for Stereotactic Body Radiation Therapy Assessment in Hepatocellular Carcinoma?Yue Cao, Kyle C Cuneo, Joseph Evans, et al.
Translational Oncology|June 25, 2014
Low dose rate radiosensitization of hepatocellular carcinoma in vitro and in patientsKyle C Cuneo, Mary A Davis, Mary U Feng, et al.
ACS Omega|October 31, 2022
Sequential Method for Analysis of CTCs and Exosomes from the Same Sample of Patient BloodJianhui Zhu, Zhijing Tan, Jie Zhang, et al.
International Journal of Radiation Oncology, Biology, Physics|October 15, 2017
Imaging Findings Within the First 12 Months of Hepatocellular Carcinoma Treated With Stereotactic Body Radiation TherapyMishal Mendiratta-Lala, Everett Gu, Dawn Owen, et al.
Neuro-Oncology Practice|November 17, 2022
Efficacy and toxicity with radiation field designs and concurrent temozolomide for CNS lymphomaAnna M Laucis, Katherine Selwa, Yilun Sun, et al.
Cell Cycle (Georgetown, Tex.)|February 19, 2016
Dissociation of gemcitabine chemosensitization by CHK1 inhibition from cell cycle checkpoint abrogation and aberrant mitotic entryLeslie A Parsels, Daria M Tanska, Joshua D Parsels, et al.
Frontiers in Oncology|December 26, 2022
A human-in-the-loop based Bayesian network approach to improve imbalanced radiation outcomes prediction for hepatocellular cancer patients with stereotactic body radiotherapyYi Luo, Kyle C Cuneo, Theodore S Lawrence, et al.
Pageof 8